Stockscreener 앱 받기
0.6649
9.14%
0.0557
시장 영업 전:
.68
0.0151
+2.27%
전일 마감가:
$0.6092
열려 있는:
$0.6249
하루 거래량:
1.86M
Relative Volume:
0.32
시가총액:
$7.45M
수익:
-
순이익/손실:
$-26.23M
주가수익비율:
-0.5417
EPS:
-1.2274
순현금흐름:
$-10.29M
1주 성능:
+8.31%
1개월 성능:
-31.52%
6개월 성능:
-62.01%
1년 성능:
-91.44%
1일 변동 폭
$0.5937
$0.675
1주일 범위
$0.5111
$0.675
52주 변동 폭
$0.3054
$9.5599
Seastar Medical Holding Corp Stock (ICU) Company Profile
명칭
Seastar Medical Holding Corp
전화
844-427-8100
주소
3513 BRIGHTON BLVD, DENVER
ICU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
0.6649 | 9.91M | 0 | -26.23M | -10.29M | -1.2274 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Seastar Medical Holding Corp 주식(ICU)의 최신 뉴스
Should I buy SeaStar Medical Holding Corporation stock before earningsFree Stock Investment Discussion Area - Newser
The ICU Stock Puzzle: Unraveling SeaStar Medical Holding Corp’s Fluctuating Performance - investchronicle.com
Leading Children's Hospital Adopts Revolutionary QUELIMMUNE Kidney Therapy as Trial Nears Completion - Stock Titan
How SeaStar Medical Holding Corporation stock performs during market volatilityTop ROI Selections - Newser
How SeaStar Medical Holding Corporation Equity Warrant stock performs during market volatilityFree Investing Community - Newser
Why SeaStar Medical Holding Corporation stock attracts strong analyst attentionProfessional Stock Screener - Newser
What makes SeaStar Medical Holding Corporation Equity Warrant stock price move sharplyFree VIP Investment Strategies - Newser
What makes SeaStar Medical Holding Corporation stock price move sharplyFree Trading Strategy Suggestions - Newser
SeaStar Medical announces registered direct offering - Medical Buyer
SeaStar Medical raises $4 million in at-market offering By Investing.com - Investing.com South Africa
SeaStar Medical raises $4 million in at-market offering - Investing.com
SeaStar Medical announces $4M registered direct offering - TipRanks
ICU pauses $7.4M ATM, leaves $6.2M unused – dilution on hold | ICU SEC FilingForm 424B5 - Stock Titan
SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI) - Yahoo Finance
SeaStar Medical shareholders approve director elections and equity plan changes - Investing.com Nigeria
SeaStar Medical shareholders approve director elections and equity plan changes By Investing.com - Investing.com South Africa
Revolutionary QUELIMMUNE Treatment Cuts Pediatric AKI Deaths by 50% at Texas Children's Hospital - Stock Titan
Medical Holding Corporation regains Nasdaq compliance - Investing.com
SeaStar Medical’s QUELIMMUNE Shows Promise in Treating Pediatric AKI - citybuzz -
SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half - The Globe and Mail
SeaStar Medical Raises $4M and Lands $15M Commitment to Save Nasdaq Listing Status - Stock Titan
Life-Saving QUELIMMUNE Therapy Success Featured by Cincinnati Children's Hospital | ICU Stock News - Stock Titan
SeaStar Medical Holding Corp Inc. (ICU) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
SeaStar Medical stock plunges after pricing million public offering - Investing.com Australia
SeaStar Medical Announces Pricing of Up to $8 Million Public Offering - The Manila Times
SeaStar Medical stock plunges after pricing million public offering By Investing.com - Investing.com India
Short Interest in SeaStar Medical Holding Corporation (NASDAQ:ICU) Rises By 29.5% - Defense World
ICU Secures U.S. DoD Grant for Advanced Burn and Injury Research - GuruFocus
Military Selects SeaStar Medical from 160 Companies for Critical Burn Treatment Research Grant - Stock Titan
How SeaStar Medical Is Leveraging Its Breakthrough Medical Device Designation To Help Critically Ill Patients - MSN
SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market - Yahoo Finance
SeaStar Medical secures second CMS trial coverage By Investing.com - Investing.com South Africa
SeaStar Medical (ICU) Secures CMS Coverage for Clinical Trial Ex - GuruFocus
SeaStar Medical secures second CMS trial coverage - Investing.com
SeaStar Medical Wins Elite CMS Coverage Status: Only 100 Trials Get This Medicare Advantage - Stock Titan
SeaStar Medical Advances Organ-Saving Therapies for Critically Ill Patients - citybuzz -
SeaStar Medical (ICU) Announces Offering of Common Stock Shares | ICU Stock News - GuruFocus
Prediction: Rocket Lab USA Is Going Global - The Globe and Mail
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
SeaStar Medical Holding Corporation (NASDAQ:ICU) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: SeaStar Medical sees revenue surge in Q1 2025 - Investing.com
SeaStar Medical Holding Corp reports results for the quarter ended March 31Earnings Summary - TradingView
SeaStar Medical Holding Corp SEC 10-Q Report - TradingView
SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance
SeaStar Medical (ICU) Hits Key Milestone in Clinical Trial | ICU Stock News - GuruFocus
SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury - Yahoo Finance
SeaStar Medical to Report First Quarter Financial Results on May 14, 2025 - Stock Titan
Medical Device Co. SeaStar Seeks Toss Of Shareholder Suit - Law360
SeaStar Medical To Report First Quarter Financial Results On May 14, 2025 - Barchart.com
ICUSeaStar Medical Holding Corp Latest Stock News & Market Updates - Stock Titan
Seastar Medical Holding Corp (ICU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Seastar Medical Holding Corp 주식 (ICU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Vincent Bernadette N | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
8,000 |
| Van Heel Kenneth | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
4,000 |
0 |
10,400 |
| Chung Kevin | Chief Medical Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
48,184 |
| Schlorff Eric | Chief Executive Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
21,667 |
0 |
98,517 |
| Baird Jennifer A | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
18,000 |
| Baird Jennifer A | Director |
Jun 30 '25 |
Buy |
0.42 |
10,000 |
4,174 |
28,000 |
| Neuman John | Director |
Jun 24 '25 |
Buy |
0.36 |
40,000 |
14,396 |
80,000 |
| Baird Jennifer A | Director |
May 20 '25 |
Buy |
1.28 |
10,000 |
12,815 |
10,000 |
| Chung Kevin | Chief Medical Officer |
May 20 '25 |
Buy |
1.25 |
4,500 |
5,625 |
18,185 |
| Neuman John | Director |
Aug 15 '24 |
Buy |
5.24 |
10,000 |
52,396 |
30,000 |
0.64%
0.37%
자본화:
|
볼륨(24시간):